A Resolution designating October 13, 2025, as "Metastatic Breast Cancer Awareness Day" in Pennsylvania.
Summary
House Resolution 49 designates October 13, 2025, as "Metastatic Breast Cancer Awareness Day" in Pennsylvania and formally recognizes the national METAvivor #LightUpMBC campaign. The resolution explains that metastatic breast cancer is stage IV disease that has spread beyond the breast to other parts of the body, and it cites national statistics on breast cancer incidence and mortality to underscore the need for awareness and research funding.
The resolution is primarily commemorative and educational rather than regulatory. It does not create new programs, benefits, reporting requirements, or enforcement provisions. Instead, it uses a state observance to highlight the distinct challenges faced by people living with metastatic breast cancer, including the limited life expectancy associated with the disease and the need for greater research investment for stage IV patients.
Impact
HR49 has no direct effect on Pennsylvania statutes, agency authority, or private legal obligations. Its practical impact is symbolic: it adds an official state observance and encourages public recognition of metastatic breast cancer, the METAvivor organization, and the #LightUpMBC awareness campaign. The resolution may help promote outreach, fundraising, and public education, but it does not amend the Pennsylvania Consolidated Statutes or appropriate state funds.
Sentiment
The available legislative history shows clear support for the resolution. The House Health Committee reported the bill as committed on a 26-0 vote, indicating unanimous committee approval and no recorded opposition in the available materials. The bill text itself is strongly supportive and advocacy-oriented, emphasizing remembrance, awareness, and research funding for metastatic breast cancer patients.
Contention
There is little evidence of controversy in the bill text or voting record. The main substantive point raised is the distinction between early-stage breast cancer awareness, commonly represented by the pink ribbon, and metastatic breast cancer, which the resolution says is not fully represented by that symbol. The resolution also reflects a policy concern that stage IV breast cancer research receives too little funding, but no opposing arguments or dissenting viewpoints are included in the provided record.